These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 21441812)

  • 1. Changes in immunohistochemical levels and subcellular localization after therapy and correlation and colocalization with CD68 suggest a pathogenetic role of Hsp60 in ulcerative colitis.
    Tomasello G; Rodolico V; Zerilli M; Martorana A; Bucchieri F; Pitruzzella A; Marino Gammazza A; David S; Rappa F; Zummo G; Damiani P; Accomando S; Rizzo M; de Macario EC; Macario AJ; Cappello F
    Appl Immunohistochem Mol Morphol; 2011 Dec; 19(6):552-61. PubMed ID: 21441812
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of Long-Term Mesalamine Therapy on Cancer-Associated Gene Expression in Colonic Mucosa of Patients with Ulcerative Colitis.
    Bajpai M; Seril DN; Van Gurp J; Geng X; Alvarez J; Minacapelli CD; Gorin S; Das KK; Poplin E; Cheng J; Amenta PS; Das KM
    Dig Dis Sci; 2019 Mar; 64(3):740-750. PubMed ID: 30478770
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prediction of steroid demand in the treatment of patients with ulcerative colitis by immunohistochemical analysis of the mucosal microenvironment and immune checkpoint: role of macrophages and regulatory markers in disease severity.
    Tsuda S; Carreras J; Kikuti YY; Nakae H; Dekiden-Monma M; Imai J; Tsuruya K; Nakamura J; Tsukune Y; Uchida T; Matsushima M; Roncador G; Suzuki T; Nakamura N; Mine T
    Pathol Int; 2019 May; 69(5):260-271. PubMed ID: 30990953
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hsp60 and Hsp10 increase in colon mucosa of Crohn’s disease and ulcerative colitis.
    Rodolico V; Tomasello G; Zerilli M; Martorana A; Pitruzzella A; Gammazza AM; David S; Zummo G; Damiani P; Accomando S; Conway de Macario E; Macario AJ; Cappello F
    Cell Stress Chaperones; 2010 Nov; 15(6):877-84. PubMed ID: 20390473
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 5-Aminosalicylic acid, a specific drug for ulcerative colitis.
    Hauso Ø; Martinsen TC; Waldum H
    Scand J Gastroenterol; 2015 Aug; 50(8):933-41. PubMed ID: 25733192
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Encapsulated mesalamine granules (Apriso) for ulcerative colitis.
    Med Lett Drugs Ther; 2009 May; 51(1312):38-9. PubMed ID: 19448588
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Convergent sets of data from in vivo and in vitro methods point to an active role of Hsp60 in chronic obstructive pulmonary disease pathogenesis.
    Cappello F; Caramori G; Campanella C; Vicari C; Gnemmi I; Zanini A; Spanevello A; Capelli A; La Rocca G; Anzalone R; Bucchieri F; D'Anna SE; Ricciardolo FL; Brun P; Balbi B; Carone M; Zummo G; Conway de Macario E; Macario AJ; Di Stefano A
    PLoS One; 2011; 6(11):e28200. PubMed ID: 22140545
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mucosal expression by B7-positive cells of the 60-kilodalton heat-shock protein in inflammatory bowel disease.
    Peetermans WE; D'Haens GR; Ceuppens JL; Rutgeerts P; Geboes K
    Gastroenterology; 1995 Jan; 108(1):75-82. PubMed ID: 7528700
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Putting rectal 5-aminosalicylic acid in its place: the role in distal ulcerative colitis.
    Marshall JK; Irvine EJ
    Am J Gastroenterol; 2000 Jul; 95(7):1628-36. PubMed ID: 10925961
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Spray dried formulation of mesalamine embedded with probiotic biomass for the treatment of ulcerative colitis:
    Thakur V; Singh A; Joshi N; Mishra N
    Drug Dev Ind Pharm; 2019 Nov; 45(11):1807-1820. PubMed ID: 31489829
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hsp10, Hsp70, and Hsp90 immunohistochemical levels change in ulcerative colitis after therapy.
    Tomasello G; Sciumé C; Rappa F; Rodolico V; Zerilli M; Martorana A; Cicero G; De Luca R; Damiani P; Accardo FM; Romeo M; Farina F; Bonaventura G; Modica G; Zummo G; Conway de Macario E; Macario AJ; Cappello F
    Eur J Histochem; 2011 Oct; 55(4):e38. PubMed ID: 22297444
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Upregulation of interleukin-12 and -17 in active inflammatory bowel disease.
    Nielsen OH; Kirman I; Rüdiger N; Hendel J; Vainer B
    Scand J Gastroenterol; 2003 Feb; 38(2):180-5. PubMed ID: 12678335
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mesalamine restores angiogenic balance in experimental ulcerative colitis by reducing expression of endostatin and angiostatin: novel molecular mechanism for therapeutic action of mesalamine.
    Deng X; Tolstanova G; Khomenko T; Chen L; Tarnawski A; Szabo S; Sandor Z
    J Pharmacol Exp Ther; 2009 Dec; 331(3):1071-8. PubMed ID: 19762547
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased production of soluble TLR2 by lamina propria mononuclear cells from ulcerative colitis patients.
    Candia E; Díaz-Jiménez D; Langjahr P; Núñez LE; de la Fuente M; Farfán N; López-Kostner F; Abedrapo M; Alvarez-Lobos M; Pinedo G; Beltrán CJ; González C; González MJ; Quera R; Hermoso MA
    Immunobiology; 2012 Jun; 217(6):634-42. PubMed ID: 22101184
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Probiotic Escherichia coli Nissle 1917 (EcN) for successful remission maintenance of ulcerative colitis in children and adolescents: an open-label pilot study.
    Henker J; Müller S; Laass MW; Schreiner A; Schulze J
    Z Gastroenterol; 2008 Sep; 46(9):874-5. PubMed ID: 18810672
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increase in colorectal epithelial apoptotic cells in patients with ulcerative colitis ultimately requiring surgery.
    Hagiwara C; Tanaka M; Kudo H
    J Gastroenterol Hepatol; 2002 Jul; 17(7):758-64. PubMed ID: 12121505
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A randomized, double blind, dose-response comparison of balsalazide (6.75 g), balsalazide (2.25 g), and mesalamine (2.4 g) in the treatment of active, mild-to-moderate ulcerative colitis.
    Levine DS; Riff DS; Pruitt R; Wruble L; Koval G; Sales D; Bell JK; Johnson LK
    Am J Gastroenterol; 2002 Jun; 97(6):1398-407. PubMed ID: 12094857
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Severe eosinophilic infiltration in colonic biopsies predicts patients with ulcerative colitis not responding to medical therapy.
    Zezos P; Patsiaoura K; Nakos A; Mpoumponaris A; Vassiliadis T; Giouleme O; Pitiakoudis M; Kouklakis G; Evgenidis N
    Colorectal Dis; 2014 Dec; 16(12):O420-30. PubMed ID: 25040651
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Curcumin add-on therapy for ulcerative colitis].
    Salomon N; Lang A; Gamus D
    Harefuah; 2015 Jan; 154(1):56-8, 66. PubMed ID: 25796678
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular mechanisms behind progressing chronic inflammatory dilated cardiomyopathy.
    Bironaite D; Daunoravicius D; Bogomolovas J; Cibiras S; Vitkus D; Zurauskas E; Zasytyte I; Rucinskas K; Labeit S; Venalis A; Grabauskiene V
    BMC Cardiovasc Disord; 2015 Mar; 15():26. PubMed ID: 25888309
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.